NONINVASIX, INC.
Optoacoustic device for noninvasive hemoglobin measurement in neonates using laser diode technology to detect signals from cerebral veins
- Sector
- Medtech
- Headquarters
- GALVESTON, TX
- Latest Form D
- $3.6M, Apr 2020
- Total capital
- $3.8M
- Federal grants
- $180K
- 1 award · 2018
- Rank in peer group#499 of 542
- Private capital raised
- $3.6M
- 1 Form D · last Apr 2020
- 79 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 8 pending · first 2019
- Rank in peer group#106 of 542
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$3.6M
- Federal grantHealth and Human S · Phase I · Noninvasive Monitoring of Total Hemoglobin Concentration in Neonates$180K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
20months
from NONINVASIX, INC.’s first federal award to its first private round.
- First federal award · Aug 2018
- Health and Human S · $180K
- First Form D · Apr 2020
- $3.6M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 542 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#106 · top 20%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Graham L. RandallResearcherExecutive Officer, DirectorLinked by $180K in grants as PI
- Donald S. ProughExecutive Officer, DirectorNamed in SEC Form D filings
- Michael S. LoweDirectorNamed in SEC Form D filings
- Thomas S. LubyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 9- PendingSequential Adaptor For Combined Ultrasound And Optoacoustic Diagnostic Interrogation Of The Left Innominate VeinUSPTOApplication 18538944
- GrantedSystems And Methods For Measuring OxygenationUSPTOUS 10,231,656
- PendingSequential Adaptor For Combined Ultrasound And Optoacoustic Diagnostic Interrogation Of The Left Innominate VeinUSPTOApplication PCTUS2022033668
Show all 9 patent records
- Sequential Adaptor For Combined Ultrasound And Optoacoustic Diagnostic Interrogation Of The Left Innominate VeinApr 25, 2024 · Application 18538944Pending
- Systems And Methods For Measuring OxygenationMar 19, 2019 · US 10,231,656Granted
- Sequential Adaptor For Combined Ultrasound And Optoacoustic Diagnostic Interrogation Of The Left Innominate VeinApplication PCTUS2022033668Pending
- Methods And Systems For Melanin Absorption-compensated Blood OxygenApplication PCTUS2025055346Pending
- Sequential Adaptor For Combined Ultrasound And Optoacoustic Diagnostic Interrogation Of The Left Innominate VeinApplication 63211541Pending
- Using An Optical Energy Meter To Normalize Acoustic Signals Generated By Laser Pulses Of Various Wavelengths To Permit Accurate Calculation Of Blood OxygenationApplication 63084706Pending
- Systems And Methods For Measuring Fetal Cerebral OxygenationApplication PCTUS2015039620Pending
- Using An Optical Energy Meter To Normalize Acoustic Signals Generated By Laser Pulses Of Various Wavelengths To Permit Accurate Calculation Of Blood OxygenationApplication PCTUS2021051608Pending
- Methods And Systems For Melanin Absorption-compensated Blood OxygenApplication 63721391Pending
Related companies, and why
- HEMEX HEALTH INCSimilar federal contract value in Medtech · null in contracts
- Spinethera, Inc.Similar federal contract value in Medtech · null in contracts
- Avails Medical, Inc.Similar federal contract value in Medtech · null in contracts
- HEARTPOINT GLOBAL INCSimilar federal contract value in Medtech · null in contracts
- BLOOMER HEALTH TECH INCSimilar federal contract value in Medtech · null in contracts
- Vixiar Medical, IncSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .